Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.15 | 0.2 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |